Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 2
1945 39
1946 95
1947 105
1948 114
1949 65
1950 26
1951 138
1952 282
1953 320
1954 322
1955 253
1956 143
1957 185
1958 142
1959 126
1960 127
1961 130
1962 89
1963 93
1964 436
1965 494
1966 517
1967 604
1968 646
1969 708
1970 728
1971 687
1972 642
1973 678
1974 663
1975 447
1976 422
1977 347
1978 386
1979 367
1980 387
1981 351
1982 345
1983 357
1984 353
1985 376
1986 358
1987 361
1988 361
1989 457
1990 467
1991 436
1992 448
1993 502
1994 533
1995 598
1996 650
1997 632
1998 758
1999 761
2000 761
2001 817
2002 916
2003 1019
2004 1070
2005 1084
2006 1229
2007 1354
2008 1414
2009 1492
2010 1644
2011 1806
2012 1992
2013 2119
2014 2180
2015 2267
2016 2218
2017 2286
2018 2228
2019 2248
2020 2680
2021 2618
2022 2345
2023 2065
2024 627

Text availability

Article attribute

Article type

Publication date

Search Results

59,873 results

Results by year

Filters applied: . Clear all
Page 1
The Diagnosis and Treatment of Tuberculosis.
Suárez I, Fünger SM, Kröger S, Rademacher J, Fätkenheuer G, Rybniker J. Suárez I, et al. Dtsch Arztebl Int. 2019 Oct 25;116(43):729-735. doi: 10.3238/arztebl.2019.0729. Dtsch Arztebl Int. 2019. PMID: 31755407 Free article. Review.
BACKGROUND: Around 10 million people worldwide contract tuberculosis every year. According to the World Health Organization (WHO), approximately one-quarter of the world's population is latently infected with Mycobacterium tuberculosis. In Ger- many, the incidence o …
BACKGROUND: Around 10 million people worldwide contract tuberculosis every year. According to the World Health Organization (WHO), ap …
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
Nahid P, Mase SR, Migliori GB, Sotgiu G, Bothamley GH, Brozek JL, Cattamanchi A, Cegielski JP, Chen L, Daley CL, Dalton TL, Duarte R, Fregonese F, Horsburgh CR Jr, Ahmad Khan F, Kheir F, Lan Z, Lardizabal A, Lauzardo M, Mangan JM, Marks SM, McKenna L, Menzies D, Mitnick CD, Nilsen DM, Parvez F, Peloquin CA, Raftery A, Schaaf HS, Shah NS, Starke JR, Wilson JW, Wortham JM, Chorba T, Seaworth B. Nahid P, et al. Am J Respir Crit Care Med. 2019 Nov 15;200(10):e93-e142. doi: 10.1164/rccm.201909-1874ST. Am J Respir Crit Care Med. 2019. PMID: 31729908 Free PMC article.
Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis (DR-TB). The document includes recommendations on the t …
Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this …
[Tuberculosis 2006].
Strausz J. Strausz J. Orv Hetil. 2007 May 6;148(18):829-31. doi: 10.1556/OH.2007.28057. Orv Hetil. 2007. PMID: 17468065 Hungarian.
However, the multidrug and extensively drug resistant bacteria challenged the otherwise effective antimicrobial therapy. In Hungary, 27 new multidrug-, and 3 new extensively drug resistant tuberculoses were detected in 2005. The recommendation of the W …
However, the multidrug and extensively drug resistant bacteria challenged the otherwise effective antimicrobial therapy. In Hu …
Drug-resistant tuberculosis.
[No authors listed] [No authors listed] Br Med J (Clin Res Ed). 1981 Aug 1;283(6287):336-7. Br Med J (Clin Res Ed). 1981. PMID: 6788314 Free PMC article. No abstract available.
Anti-tuberculosis drug delivery for tuberculous bone defects.
Hua L, Qian H, Lei T, Liu W, He X, Zhang Y, Lei P, Hu Y. Hua L, et al. Expert Opin Drug Deliv. 2021 Dec;18(12):1815-1827. doi: 10.1080/17425247.2021.2005576. Epub 2022 Jan 3. Expert Opin Drug Deliv. 2021. PMID: 34758697 Review.
INTRODUCTION: Traditional therapy methods for treating tuberculous bone defects have several limitations. Furthermore, systemic toxicity and disease recurrence in tuberculosis (TB) have not been effectively addressed. AREAS COVERED: This review is based on reference …
INTRODUCTION: Traditional therapy methods for treating tuberculous bone defects have several limitations. Furthermore, systemic toxic …
Chemotherapy of Tuberculosis.
Dobbs TE, Webb RM. Dobbs TE, et al. Microbiol Spectr. 2017 Apr;5(2). doi: 10.1128/microbiolspec.TNMI7-0040-2017. Microbiol Spectr. 2017. PMID: 28387179 Free article. Review.
The management of tuberculosis (TB) can be a challenging process that has implications both for the affected patient and public health. ...Recommended regimens address the complexities of eliminating organisms from diverse reservoirs while preventing the emergence of dr …
The management of tuberculosis (TB) can be a challenging process that has implications both for the affected patient and public healt …
Overcoming drug resistance for tuberculosis.
Poce G, Biava M. Poce G, et al. Future Microbiol. 2015;10(11):1735-41. doi: 10.2217/fmb.15.76. Epub 2015 Oct 30. Future Microbiol. 2015. PMID: 26516679 Review.
Despite enormous progress, tuberculosis (TB) is still a major global health problem. Poor patients' adherence to the current treatment leads to the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) strains. While increased numbers of MDR-TB …
Despite enormous progress, tuberculosis (TB) is still a major global health problem. Poor patients' adherence to the current treatmen …
Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis.
Greenstein T, Aldridge BB. Greenstein T, et al. Front Cell Infect Microbiol. 2023 Jan 6;12:1085946. doi: 10.3389/fcimb.2022.1085946. eCollection 2022. Front Cell Infect Microbiol. 2023. PMID: 36733851 Free PMC article. Review.
In this review, we discuss the factors underlying types of drug tolerance, how combination therapy targets these populations of bacteria, and how drug tolerance is currently modeled for the development of tuberculosis multidrug therapy. We highl …
In this review, we discuss the factors underlying types of drug tolerance, how combination therapy targets these populations o …
Short-course therapy for tuberculosis.
Aquinas M. Aquinas M. Drugs. 1982 Aug;24(2):118-32. doi: 10.2165/00003495-198224020-00002. Drugs. 1982. PMID: 6749471 Review.
Rifampicin has proven to be highly effective and vital to short-course tuberculosis therapy, but its disadvantage is its cost. This makes it relatively unavailable where it is most needed, i.e. in countries where tuberculosis is still rampant, but which are e …
Rifampicin has proven to be highly effective and vital to short-course tuberculosis therapy, but its disadvantage is its cost. …
59,873 results
You have reached the last available page of results. Please see the User Guide for more information.